Postoperative Tumor-Informed Circulating Tumor DNA Status for Molecular Residual Disease Detection After Curative-Intent Resection of Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-Analysis.
Blood tests detecting leftover cancer DNA after pancreatic surgery identified patients at higher recurrence risk, informing closer monitoring decisions.
This systematic review and meta-analysis examined Postoperative Tumor-Informed Circulating Tumor DNA Status for Molecular Residual Disease Detection After Curative-Intent Resection of Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-Analysis. Postoperative tumor-informed ctDNA positivity was associated with an increased recurrence risk and inferior survival after curative-intent PDAC treatment, although a negative result did not reliably exclude residual disease.
What the study was
- Study design
- Systematic review and meta-analysis
- Sample size
- 237
- Category
- Early Detection
- Maturity
- Validated
- Journal
- Journal of gastrointestinal cancer
Why it surfaced
Retained after review of PubMed metadata and abstract because its systematic review and meta-analysis directly informs early cancer detection; scoring was capped conservatively for design and evidence maturity.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.